Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1983-05-11
1984-12-25
Waltz, Thomas A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2604105, 2604106, 2604109, 260413, 260404, 424314, 424318, 424320, 424324, 2604109V, C07C 5703, C07C 69587, C07C103133, A61K 3123
Patent
active
044904142
ABSTRACT:
Open ring retinoic acid analogues and 2Z isomers of the formula ##STR1## where X is ##STR2## and R is hydroxy, alkoxy with 0 or 1 hydroxy substituent, aroxy with 0 or 1 hydroxy or alkoxy-monosubstituted phenoxy or NR.sup.1 R.sup.2 where R.sup.1 is hydrogen, alkyl, or aryl and R.sup.2 is alkyl or aryl are disclosed. These retinoids are useful as chemopreventive agents for inhibiting tumor promotion in epithelial cells and for treating nonmalignant skin disorders.
REFERENCES:
patent: 3746730 (1973-07-01), Marbet
patent: 3781314 (1973-12-01), Bollag et al.
patent: 4107193 (1978-08-01), Kijima et al.
patent: 4147708 (1979-04-01), Manchand
Chan Rebecca L. S.
Dawson Marcia I.
SRI - International
Waltz Thomas A.
LandOfFree
Open chain analogues of retinoic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Open chain analogues of retinoic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Open chain analogues of retinoic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1152688